Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1Rectal Neoplasms 1Primary Peritoneal Neoplasm 1Postoperative Complications 1Patients Undergoing Open Resection of Colorectal Tumours 1Neoplasm Metastasis 1Hemorrhage 1Hearing Loss 1Fluid and Electrolyte Imbalance 1Ear Neoplasms 1Diverticulitis 1Crohn Disease 1Colonic Polyps 1Colonic Neoplasms 1Colitis, Ulcerative 1

Interventions

Ankle Brachial Index 2Acetylcysteine 2sodium thiosulfate 1Tomography, X-Ray Computed 1Saline Solution 1Ringer's Lactate 1Radiosurgery 1Platinum 1Ofloxacin 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Hearing Tests 1Hearing 1Genetic Association Studies 1Ear Protective Devices 1Cisplatin 1Carboplatin 1Audiometry, Pure-Tone 1Acoustic Impedance Tests 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hearing Loss × Ringer's Lactate × Clear all
NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡